A detailed history of Orbimed Advisors LLC transactions in Next Cure, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 1,141,200 shares of NXTC stock, worth $1.36 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,141,200
Previous 1,141,200 -0.0%
Holding current value
$1.36 Million
Previous $1.81 Million 13.84%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.13 - $2.23 $1.77 Million - $3.5 Million
-1,569,813 Reduced 57.91%
1,141,200 $2.54 Million
Q2 2019

Aug 14, 2019

BUY
$14.16 - $20.64 $38.4 Million - $56 Million
2,711,013 New
2,711,013 $40.6 Million

Others Institutions Holding NXTC

About NextCure, Inc.


  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $33M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.